Jim Cramer's Mad Money In-Depth Stock Picks, Feb. 7

Stocks discussed in the in-depth session of Jim Cramer’s Mad Money TV program, Wednesday February 7. Click on a stock ticker for more analysis:

Nike Wannabee: Under Armour (UA), Crocs (CROX), Nike (NKE)

Broadcasting from the Darden School of Business at the University of Virginia, Cramer dedicated his back-to-school program to searching for the next Nike, and examined likely candidates UA and CROX. Nike is worth emulating because it has a "great brand" and is also a "global brand" with instant name recognition. Cramer commented that while both UA and CROX seem like fads, it is important to look beyond trends to find a stock which will stand the test of time. He was happy to report that CROX is up double since his recommendation in September and is "flying high" while UA "hit a wall" only to rise again on rumors that it may be a takeover target. UA has extended its brand to include football cleats and is expanding into Europe and Asia. In addition, Cramer observes that UA has promising guidance and that its revenue is up 30%. Looking at Crox, Cramer comments on its stellar growth, but does not see a potential for the company to extend its brand; "It is, in the end, just a shoe company," he said. Although it has international prospects, 30% of CROX's sales are already overseas. Cramer likes CROX as a short-term play for the next quarter or two but believes it will eventually "hit the wall and never recover." However, he feels that the 36% short position on the stock is premature, and a short squeeze may lift the stock. Cramer declares Under Armour the next Nike, and is bullish on the stock for the long term.

CEO Interview: Robert Hugin, Celgene (CELG)

When Cramer asked Robert Hugin if Celgene has already exhausted its potential, he responded "We've had a great performance, but the best is yet to come." Hugin discussed CELG's cancer medication, Revlimid, which has made a difference for many patients. Revlimid is the first of a series of drugs called IMiDS, and there are two other IMiDS currently in clinics. Cramer commented that while some are giving up on CELG, he believes in the company.

Clearwater Creek (CWTR)

Cramer admitted his error in touting CWTR, saying that he thought it was a good regional-to-national story and believed in its management. However, rather than blaming the management, he claimed full responsibility for the error in judgement.

Seeking Alpha publishes a summary of Jim Cramer's stock picks every day including: Mad Money Recap, Lightening Round, Stop Trading and his Market Minute.

Get Cramer's Picks by email -- it's free and takes only a few seconds to sign up.

Seeking Alpha is not affiliated with Jim Cramer, CNBC or TheStreet.com